0000950170-24-099168.txt : 20240820 0000950170-24-099168.hdr.sgml : 20240820 20240820164502 ACCESSION NUMBER: 0000950170-24-099168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240816 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sorensen Mel CENTRAL INDEX KEY: 0001444783 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 241225853 MAIL ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 4 1 ownership.xml 4 X0508 4 2024-08-16 0001563577 Galera Therapeutics, Inc. GRTX 0001444783 Sorensen Mel C/O GALERA THERAPEUTICS, INC., 45 LIBERTY BLVD #230 MALVERN PA 19355 true true false false President and CEO false Common Stock 2024-08-16 4 S false 67015 0.0720 D 265029 D /s/ Chris Degnan, Attorney-in-Fact for J. Mel Sorensen 2024-08-20